| INTRODUCTION
Colorectal cancer (CRC) is widespread worldwide, and despite improvement in treatment still leads to morbidity and mortality. 1 Many risk factors have a role in development of colon cancer. These risk factors may increase the rate of genetic mutations, and/or result in epigenetic modifications. These factors can be classified into: germline genetic mutations, associated diseases, personal or family history of CRC, environmental exposures, and demographic considerations. 2 Small mother against decapentaplegic-7 (Smad-7) is a nuclear protein, and can transport between the cytoplasm and the nucleus.
It negatively regulate TGF-β signaling by multiple mechanisms as by blocking the phosphorylation of receptor-activated Smads or by competitive inhibition of complex formation of receptor activated
Smads with common-mediated Smad4. Epithelial tissues show a very low expression level of Smad7, but it is upregulated in human pancreatic cancers. 3 Genome-wide association studies (GWAS) showed that common alleles of Smad7 influence the risk of CRC. 4 Boulay et al. 5 showed that deletion of Smad7 brought better prognosis than patients with two copies of this gene, whereas increased copies of that gene is associated with a significantly bad prognosis.
The Smad7 gene encodes a protein that binds with the transforming growth factor (TGF)-β type I receptor, this causes its degradation and so inhibiting the phosphorylation of Smad2/Smad3 byTGF-β1. Smad-7 can bind also with intracellular proteins and organize cell function by TGF-β1-independent pathways. Overexpression of Smad7 is accompanied by the development of many types of cancers as pancreatic, skin and lung cancers. MiR-375 is known as a pancreatic islet-specific miRNA as it regulates insulin secretion induced by glucose. 8 However, genome-wide miRNA expression profiling studies revealed that miR-375 is widely spread in tissues and organs and is significantly reduced in malignant cell, as hepatocellular carcinoma (HCC), gastric cancer (GC), esophageal carcinoma, head and neck cancer, it is considered an important cancer-related miRNA. 
| Aim of the work
Our aim was to study the expression of microRNA-375 and its target gene SMAD-7 polymorphisms in colorectal cancer patients in comparison to control subjects and to correlate these results with clinical data of patient group to elucidate their role in pathogenesis and early diagnosis of CRC. Genotyping was performed using real-time polymerase chain reaction (RT-PCR) with the Taq Man allelic discrimination assay using predesigned primer/probe sets SMAD7 r s4939827 (C_27913406_10) (Applied Biosystems, Foster City, CA, USA). DNA amplification was carried out in a 25 μL volume containing 12.5 μL Taqman master mix, cycles at 60°C for 90 seconds and at 92°C for 15 seconds for annealing and extension were carried out, and fluorescence was measured at the end of every cycle and at the endpoint.
| SUBJECTS AND METHODS

| STATISTICAL ANALYSIS
Data were collected and coded to facilitate data manipulation and double entered into Microsoft Access and data analysis was performed using SPSS software version 18 under windows 7 (SPSS Inc.,
Chicago, IL, USA). Simple descriptive analysis in the form of numbers
and percentages for qualitative data, and arithmetic means as central tendency measurement, standard deviations as measure of dispersion for quantitative parametric data, and inferential statistic test.
| For quantitative parametric data
Independent student t-test used to compare measures of two independent groups of quantitative data. One-way ANOVA test was used in comparing more than two independent groups of quantitative data.
| For quantitative non parametric data
Kruskal-Wallis and Mann-Whitney tests were used in comparing more than two independent groups.
ROC curve "Receiver Operating Characteristic" was used to determine the Sensitivity and specificity for the microRNA-375.
| RESULTS
There were 122 subjects enrolled in our study, including 86 CRC patients and 36 controls. General characteristics of all subjects are listed in Table 1 . It was shown that age, gender, and BMI were not significantly different between cases and controls. Description of site of tumor among cases was shown also in Table 1 . A highly significant correlation was found between miRNA-375 level and mutant and heterozygotes genotypes of SMAD-7 rs4939827 polymorphism in CRC (Table 3) . Roc curve showed the sensitivity and specificity test for fold change in microRNA -375, they were 89.5%, 100%, respectively, with cut-off value of 0.6547. causes abdominal pain. 11 Occult blood immunochemical test is convenient and inexpensive, but still has low sensitivity and specificity. Meanwhile, we aimed to study the expression of microRNA-375
| DISCUSSION
and its target gene SMAD-7 polymorphism (rs4939827) in colorectal cancer patients in comparison to control subjects and to correlate these results with clinical data of patient group to elucidate their role in pathogenesis and early diagnosis of the disease.
We studied the rs4939827 SNP of SMAD-7 in CRC patients and controls. We found that the wild type CC genotype has higher percentage in controls compared to cases (P=.01). The mutant genotype as well as the heterozygote genotype had higher percentage in patients than in controls. To some extent, this percentage is similar to the percentages of Kirac et al. 13 in which the proportion of each of the rs4939827 genotypes CC, CT and TT was 29%, 49%, and 22% in controls, respectively, and 21%, 47%, and 32% in cases, respectively.
This results are also coincided in part with Abd Elfattah et al., 16 who stated that SMAD7 rs4939827 TT genotype was associated with the rectal cancer but not the colon cancer as the frequency (13/30, 43%) in the rectal cancer patients than the colon cancer patients (9/47, 19%) at P=.042. No significant difference was found in the allele frequencies (P=.16) between the colon and the rectal cancer patients.
The association with rectal more than colon may be explained by the involvement of the TGF-β signaling with malignant transformation of adenomas driven by chromosomal instability that occurs mainly in the rectum.
17
In the present study, found higher frequency of allele T in CRC than in controls (59.3% vs 43.1% respectively, P=.02) and allele C among controls than patients (56.9% vs 40.6% respectively, P=.02). Kirac et al., 13 coincided with us as they found that the T allele frequency in Croatian populations (AFT=49.6%). At the same time, T allele frequency in European populations was (AFT=52.9%).
Our results are coincided with Yan et al., 18 who revealed that the Another study revealed that miR-375 reduced cell viability through the induction of apoptotic death by targeting YAP. 28 To the best of our knowledge, our study is the first to detect significant correlation between microRNA (-375) and SMAD-7 polymorphism in which there is high mean of fold change in miRNA-375 among individuals with TT, and low mean among individual with CT.
On the other hand, there is no statistically significance difference with P>0.05 between study groups as regards to CC genotype.
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In conclusion, micro RNA-375 and rs4939827 SNP of SMAD7gene could be considered as potential noninvasive markers for detecting and early diagnosing CRC.
